Challenges in RCC Imaging: Renal Insufficiency, Post-Operative Surveillance, and the Role of Radiomics.
发表日期： 2015.11 来源：Kidney Cancer Journal. 2015 Nov; 13(4): 84–90.
Nicholas J Farber1, Yan Wu2,3 , Lily Zou3, Puneet Belani3, and Eric A Singer1,2.
1. Rutgers Robert Wood Johnson Medical School, Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey, 195 Little Albany Street, Room 4563 New Brunswick, NJ 08903, USA
2. Center for Biomedical Imaging & Informatics, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, 195 Little Albany Street, New Brunswick, NJ 08903, USA
3. Rutgers Robert Wood Johnson Medical School, Department of Radiology, MEB #404 P.O. Box 19, New Brunswick, NJ 08903, USA
Renal cell carcinoma (RCC) is the third most common cancer of the genitourinary system and in 2015 will account for an estimated 61,560 new cases and 14,080 deaths in the United States 1. Over the past several decades, the incidence of RCC has risen steadily by approximately 2-4% annually 2. Imaging plays an integral role in the evaluation and management of a patient with a renal mass, from the preoperative workup to the postoperative surveillance. Unfortunately, in clinical practice the urologist is often faced with imaging dilemmas that lack definitive answers. Herein we explore the current data behind contemporary imaging topics, including imaging a patient with renal insufficiency, establishing a surveillance protocol after RCC therapy, minimizing radiation therapy during surveillance, and emerging imaging trends.
Renal cell carcinoma imaging; diffusion MRI; kidney cancer surveillance; molecular imaging; perfusion MRI; radiation exposure
阅读原文：PMID: 26937265 PMCID: PMC4770557